Clinical trials
Neurofibroma, Plexiform trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Novartis Pharmaceuticals | 1 |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurofibroma, Plexiform | 3 |
| Neurofibromatosis 1 | 3 |
| Astrocytoma | 1 |
| Ganglioglioma | 1 |
| Ganglioneuroma | 1 |
| Glioblastoma | 1 |
| Glioma | 1 |
| Histiocytosis, Langerhans-Cell | 1 |
| Neuroblastoma | 1 |
| Neurocytoma | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.